Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Leukemia 28 Prostatic Neoplasms 21 Burkitt Lymphoma 17 Leukemia, Biphenotypic, Acute 15 Lymphoma 13 Leukemia, Myeloid, Acute 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large B-Cell, Diffuse 6 Recurrence 5 Lymphoma, Non-Hodgkin 5 Myelodysplastic Syndromes 4 Hodgkin Disease 4 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Lymphoma, T-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Rhabdoid Tumor 2 Polycystic Ovary Syndrome 2 Obesity 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 Standard of Care 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Midazolam 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Hydrocortisone × Clear all

NCT06136624 2026-05-05

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡